{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:49:36Z","timestamp":1783734576302,"version":"3.55.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Proteins with repeat domains are commonly found in protozoan parasites.\n                    <jats:italic>Trypanosoma cruzi<\/jats:italic>\n                    , which causes Chagas disease (CD), possesses a group of surface proteins called trans-sialidases (TS). These proteins are responsible for transferring sialic acid from the host\u2019s glycoconjugates to the parasite\u2019s mucins. The TS proteins feature a C-terminal immunogenic domain that includes amino acid repeats known as SAPA (Shed Acute Phase Antigen). Shed in the blood of the infected host, TS mediates several biological effects and because of its essential role during infection, it has been tested recurrently as a vaccine candidate against CD. Here, we investigate the effect of immunizing mice with recombinant TS proteins with and without (w\/o) SAPA repeats, as well as with a protein containing only the repeat domain. We also immunize mice with RNA formulations encoding TS sequences with and without SAPA. Besides confirming the immunodominance of the SAPA domain, after challenging immunized animals with\n                    <jats:italic>T. cruzi<\/jats:italic>\n                    , we showed that the presence of the repeats did not significantly impact protection and parasite numbers after infection. However, immunization with TS protein or RNA containing the repeat domain resulted in increased production of IL-10 compared to mice immunized with TS without SAPA, and this increased IL-10 production correlates with a significant reduction in the inflammatory infiltrate in heart tissues of infected animals. These results indicate that the immunodominant SAPA domain plays a role in promoting an anti-inflammatory response, which, as a vaccine component, may contribute to induce a desirable, more balanced immune response.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2025.1681807","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:31:25Z","timestamp":1760679085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response"],"prefix":"10.3389","volume":"15","author":[{"given":"Nailma Silva Aprigio","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"de Almeida-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra Fernanda","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo C. O.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Salgado","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela de A.","family":"Burle-Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Teixeira","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Lu\u00eds","family":"Reis-Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella C.","family":"Bartholomeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara Martins","family":"Meira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaiane Gomes","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Fernanda de Melo","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo T.","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santuza M. R.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0166-6851(89)90050-9","article-title":"Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas\u2019 disease","volume":"34","author":"Affranchino","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.str.2004.02.036","article-title":"Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase","volume":"12","author":"Amaya","year":"2004","journal-title":"Structure"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1128\/IAI.73.9.6017-6025.2005","article-title":"CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2","volume":"73","author":"Ara\u00fajo","year":"2005","journal-title":"Infect. Immun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"W202","DOI":"10.1093\/nar\/gkp335","article-title":"MEME SUITE: tools for motif discovery and searching","volume":"37","author":"Bailey","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/nar\/27.2.573","article-title":"Tandem repeats finder: a program to analyze DNA sequences","volume":"27","author":"Benson","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000177","article-title":"Expanding an expanded genome: long-read sequencing of Trypanosoma cruzi","volume":"4","author":"Bern\u00e1","year":"2018","journal-title":"Microb. Genom"},{"key":"B7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2217\/imt-2017-0009","article-title":"Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi","volume":"9","author":"Bontempi","year":"2017","journal-title":"Immunotherapy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.vaccine.2015.01.044","article-title":"Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease","volume":"33","author":"Bontempi","year":"2015","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03478-21","article-title":"Disruption of active trans-sialidase genes impairs egress from mammalian host cells and generates highly attenuated Trypanosoma cruzi parasites","volume":"13","author":"Burle-Caldas","year":"2022","journal-title":"mBio"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1182\/blood.V93.6.2025.406k19_2025_2032","article-title":"Tandem amino acid repeats from Trypanosoma cruzi shed antigens increase the half-life of proteins in blood","volume":"93","author":"Buscaglia","year":"1999","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005902","article-title":"Th17 cells are more protective than th1 cells against the intracellular parasite Trypanosoma cruzi","volume":"12","author":"Cai","year":"2016","journal-title":"PLoS Pathog."},{"key":"B12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1590\/S0036-46651964000300002","article-title":"Growth and differentiation in Trypanosoma Cruzi. I. Origin of metacyclic trypanosomes in liquid media","volume":"6","author":"Camargo","year":"1964","journal-title":"Rev. Inst Med. Trop. Sao Paulo."},{"key":"B13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1590\/S0074-02761999000700064","article-title":"Criteria of Chagas disease cure","author":"Can\u00e7ado","year":"1999","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41541-023-00676-0","article-title":"ASP-2\/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas\u2019 disease","volume":"8","author":"Castro","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4497","article-title":"BepiPred-3.0: Improved B-cell epitope prediction using protein language models","volume":"31","author":"Clifford","year":"2022","journal-title":"Protein Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1086\/596061","article-title":"Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy","volume":"199","author":"Costa","year":"2009","journal-title":"J. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0378-1119(95)00175-6","article-title":"A single tyrosine differentiates active and inactive Trypanosoma cruzi trans-sialidases","volume":"160","author":"Cremona","year":"1995","journal-title":"Gene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1590\/S0100-879X1999000200008","article-title":"MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans","volume":"32","author":"Cunha-Neto","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.768450","article-title":"-Sialidase as a Potential Vaccine Target Against Chagas Disease","volume":"11","author":"da Costa","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00436-001-0540-0","article-title":"Characterization of cDNA clones encoding ribonucleoprotein antigens expressed in Trypanosoma cruzi amastigotes","volume":"88","author":"DaRocha","year":"2002","journal-title":"Parasitol. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/femsre\/fux046","article-title":"Repetitive sequences in malaria parasite proteins","volume":"41","author":"Davies","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/j.1462-5822.2012.01831.x","article-title":"T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas\u2019 disease","volume":"14","author":"Dc-Rubin","year":"2012","journal-title":"Cell Microbiol."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/295394","article-title":"Review on Trypanosoma cruzi: host cell interaction","volume":"2010","author":"de Souza","year":"2010","journal-title":"Int. J. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed6010016","article-title":"The case for the development of a Chagas disease vaccine: Why? How? When","volume":"6","author":"Dumonteil","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease","volume":"309","author":"El-Sayed","year":"2005","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1574-6976.2012.00333.x","article-title":"Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence","volume":"36","author":"Fernandes","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12951-025-03201-8","article-title":"The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens","volume":"23","author":"Fernandes","year":"2025","journal-title":"J. Nanobiotechnology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.vaccine.2008.02.060","article-title":"Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate","volume":"26","author":"Fontanella","year":"2008","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0169-4758(00)01698-7","article-title":"Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi","volume":"16","author":"Frasch","year":"2000","journal-title":"Parasitol. Today"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13388","DOI":"10.1074\/jbc.M109.096305","article-title":"Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses","volume":"285","author":"Freire-de-Lima","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025914","article-title":"Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity","volume":"6","author":"Freitas","year":"2011","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.671104","article-title":"Targeting myeloid-derived suppressor cells to enhance a trans-sialidase-based vaccine against","volume":"11","author":"Gamba","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/intimm\/14.3.299","article-title":"The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion","volume":"14","author":"Gao","year":"2002","journal-title":"Int. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/IAI.00278-09","article-title":"Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges","volume":"78","author":"Giddings","year":"2010","journal-title":"Infect. Immun."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.723549","article-title":"Induces regulatory B cell alterations in patients with chronic Chagas disease","volume":"11","author":"Girard","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1128\/IAI.00604-08","article-title":"Immunological dominance of Trypanosoma cruzi tandem repeat proteins","volume":"76","author":"Goto","year":"2008","journal-title":"Infect. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.4049\/jimmunol.179.10.6889","article-title":"Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming","volume":"179","author":"Hoft","year":"2007","journal-title":"J. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.4049\/jimmunol.158.7.3311","article-title":"IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi","volume":"158","author":"Hunter","year":"1997","journal-title":"J. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.mi.41.100187.001145","article-title":"Repetitive proteins and genes of malaria","volume":"41","author":"Kemp","year":"1987","journal-title":"Annu. Rev. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12020171","article-title":"Cytokine networks as targets for preventing and controlling Chagas heart disease","volume":"12","author":"Koh","year":"2023","journal-title":"Pathogens"},{"key":"B42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/17512433.2018.1509704","article-title":"Clinical and pharmacological profile of benznidazole for treatment of Chagas disease","volume":"11","author":"Kratz","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010999","article-title":"High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire","volume":"18","author":"Kucharska","year":"2022","journal-title":"PloS Pathog."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas disease: from discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front. Public Health"},{"key":"B45","doi-asserted-by":"publisher","first-page":"145501","DOI":"10.1016\/j.ijbiomac.2025.145501","article-title":"Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases","volume":"319","author":"Lu","year":"2025","journal-title":"Int. J. Biol. Macromol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/molbev\/mst001","article-title":"Repeat-enriched proteins are related to host cell invasion and immune evasion in parasitic protozoa","volume":"30","author":"Mendes","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2174\/1568026616666161025161858","article-title":"Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment","volume":"17","author":"Menna-Barreto","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1128\/IAI.68.6.3574-3580.2000","article-title":"The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen","volume":"68","author":"Millar","year":"2000","journal-title":"Infect. Immun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.bbapap.2011.04.012","article-title":"Crystal structure of an enzymatically inactive trans-sialidase-like lectin from Trypanosoma cruzi: the carbohydrate binding mechanism involves residual sialidase activity","volume":"1814","author":"Oppezzo","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B50","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.4049\/jimmunol.168.12.6366","article-title":"The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection","volume":"168","author":"Ouaissi","year":"2002","journal-title":"J. Immunol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101171","article-title":"Intranasal trans-sialidase vaccine mitigates acute and chronic pathology in a preclinical oral Chagas disease model","volume":"12","author":"Pacini","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004594","article-title":"A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy","volume":"11","author":"Pereira","year":"2015","journal-title":"PloS Pathog."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.mcpro.2021.100122","article-title":"Allele-specific thresholds of eluted ligands for T-cell epitope prediction","volume":"20","author":"Reardon","year":"2021","journal-title":"Mol. Cell Proteomics."},{"key":"B55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"B56","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1021\/acsinfecdis.4c00623","article-title":"Zileuton, a 5-lypoxigenase inhibitor, is antiparasitic and prevents inflammation in the chronic stage of heart Chagas disease","volume":"10","author":"Ricci","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4049\/jimmunol.1003845","article-title":"IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection","volume":"188","author":"Roff\u00ea","year":"2012","journal-title":"J. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1128\/IAI.00031-15","article-title":"Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells","volume":"83","author":"Ruiz D\u00edaz","year":"2015","journal-title":"Infect. Immun."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00128","article-title":"Mucosal heterologous prime\/boost vaccination induces polyfunctional systemic immunity, improving protection against","volume":"11","author":"Sanchez Alberti","year":"2020","journal-title":"Front. Immunol."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000931","article-title":"International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients","volume":"5","author":"Schijman","year":"2011","journal-title":"PloS Negl. Trop. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0169-4758(91)90166-L","article-title":"On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasites","volume":"7","author":"Schofield","year":"1991","journal-title":"Parasitol. Today"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009759","article-title":"The increased presence of repetitive motifs in the KDDR-plus recombinant protein, a kinesin-derived antigen from Leishmania infantum, improves the diagnostic performance of serological tests for human and canine visceral leishmaniasis","volume":"15","author":"Siqueira","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.lana.2025.101059","article-title":"The time has come for a vaccine against Chagas disease","volume":"45","author":"Teixeira","year":"2025","journal-title":"Lancet Reg. Health Am."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02188","article-title":"Down modulation of host immune response by amino acid repeats present in a","volume":"8","author":"Toro Acevedo","year":"2017","journal-title":"Front. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific chemotherapy of Chagas disease: controversies and advances","volume":"19","author":"Urbina","year":"2003","journal-title":"Trends Parasitol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","article-title":"Sialic acids in human health and disease","volume":"14","author":"Varki","year":"2008","journal-title":"Trends Mol. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009254","article-title":"Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease","volume":"17","author":"Wang","year":"2021","journal-title":"PLoS Pathog."},{"key":"B71","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B72","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.1093\/nar\/gkac373","article-title":"IBS 2.0: an upgraded illustrator for the visualization of biological sequences","volume":"50","author":"Xie","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"35508","DOI":"10.1074\/jbc.M305030200","article-title":"Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI","volume":"104","author":"Zingales","year":"2009","journal-title":"Mem Inst Oswaldo Cruz."}],"updated-by":[{"DOI":"10.3389\/fcimb.2025.1729034","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000}}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1681807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:11:25Z","timestamp":1764087085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1681807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":74,"alternative-id":["10.3389\/fcimb.2025.1681807"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1681807","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"article-number":"1681807"}}